Beryl Drugs Board Meeting on Nov 14 to Approve Unaudited Results

Beryl Drugs Ltd has announced that its Board of Directors meeting is scheduled for November 14, 2026. The primary agenda items include the consideration and approval of the unaudited financial results for the quarter ended September 30, 2026, along with the adoption of the Limited Review Report for the same period. Additionally, the company will address other routine business matters. The trading window for securities will reopen 48 hours after the conclusion of this board meeting.